Cuban: PBMs exclude $700 biosimilar Usimri to protect drug margin revenues
Mark Cuban · Sharks Never Stop Swimming: A Conversation with Mark Cuban · Mar 5, 2024 · at 10:33
Mark Cuban explains why Pharmacy Benefit Managers refuse to cover cheaper biosimilars like Usimri compared to brand-name drug Humira.
0:00 / 0:16exact quote · 16.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Humira is about 8000 dollars a month. Six to 8000 dollars a month. USIMRI is about 700 dollars a month. But they won't add USIMRI to their formularies because they don't want to use the revenue in the margin.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Mark Cuban
Mark Cuban calls Zohran Mamdani a progressive Trump who lies to voters
“He learned from Trump. He's the progressive Trump. Just lie. You know, Day one, groceries are going to be cheaper. I'll just, I'll open the grocery store because I'll sound more progressive that way, right? Day one, buses are free. And then everything else, he…”
Mark Cuban says research hospitals are idiots to publish or patent IP
“Because if I'm MD Anderson, if I'm Stanford, any research hospital, any scientist in healthcare, you're an idiot if you publish it. You're an idiot if you patent it. Because it's immediately going to get absorbed into a large language model. And you've lost co…”
Mark Cuban says Pharmacy Benefit Managers are the core problem in healthcare
“You know, everybody, Amazon, everybody else. Okay. We're going to work with the big PBMs. Cause that's where the money is. And I'm like, no, they're the problem.”
Mark Cuban says only Steph Curry and LeBron James are arena draws
“There's only like two players that fill an arena. Steph and LeBron.”